Related Experiment Videos
Interference of Apoptosis by Hepatitis B Virus
1Molecular Virology Laboratory, VA-MD College of Veterinary Medicine and Maryland Pathogen Research Institute, University of Maryland, College Park, MD 20742, USA. lsl1990@umd.edu.
Viruses
|August 19, 2017
Summary
Hepatitis B virus (HBV) disrupts programmed cell death (apoptosis) to drive liver cancer (HCC) and viral spread. This review explores how HBV interferes with apoptosis signaling, focusing on the HBV X protein (HBX).
Area of Science:
- Hepatology
- Virology
- Cancer Biology
Background:
- Hepatitis B virus (HBV) infection is a major global health concern, causing significant liver disease and contributing to over a million deaths annually.
- Chronic HBV infection is strongly linked to a large proportion of hepatocellular carcinoma (HCC) cases worldwide.
- Apoptosis, a critical process of programmed cell death, is frequently dysregulated during cancer development.
Purpose of the Study:
- To review recent studies on the mechanisms by which HBV interferes with apoptosis signaling pathways.
- To elucidate the role of HBV X protein (HBX) in modulating apoptosis during infection.
- To provide insights into the conflicting reports regarding HBV's effect on apoptosis (inhibition vs. induction).
Main Methods:
- Literature review of recent scientific studies.
- Analysis of mechanisms involving cellular signaling pathways.
- Examination of epigenetic regulation in HBV-associated apoptosis alteration.
Main Results:
- HBV infection interferes with apoptosis signaling to promote HCC progression and viral replication.
- The HBV X protein (HBX) is a key factor in mediating this interference.
- Conflicting evidence exists, with studies reporting both inhibition and induction of apoptosis by HBV.
Conclusions:
- HBV significantly alters apoptosis, contributing to liver disease and cancer development.
- Understanding these mechanisms, particularly HBX's role, is crucial for therapeutic strategies.
- Further research is needed to reconcile conflicting findings on HBV's impact on apoptosis.